gibreel ferishta
MUMBAI: Roche Ltd, the Indian arm of Swiss drugmaker F Hoffman La Roche Scientific, has won a trademark-infringement case against Cipla Ltd over its anti-infection drug brand-named Valcyte.
The Bombay High Court found Cipla’s brandname ‘Valcept’ —- for the generic version of the drug valganciclovir —- infringing upon Roche’s trademark rights.
The court has given Cipla three weeks to change the brand-name of its version.
Generic drugs are copycats versions of innovator drugs, and are sold far cheaper. Cipla’s Valcept is priced at Rs 245 per tablet against Roche Valcyte’s Rs 1,000.
trademark IP generics Cipla Roche valcyte valcept
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.